Evidence map›Paper›PMID 38667168›Full record

ArticleBiosensors2024

An Extracellular Matrix Overlay Model for Bioluminescence Microscopy to Measure Single-Cell Heterogeneous Responses to Antiandrogens in Prostate Cancer Cells.

Audrey Champagne, Imene Chebra, Pallavi Jain, Cassandra Ringuette Goulet, Annie Lauzier, Antoine Guyon, Bertrand Neveu, Frédéric Pouliot

Open access · goldAbstract read
In one paragraph

Article in Biosensors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Audrey ChampagneCentre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Imene ChebraCentre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Pallavi JainCentre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Cassandra Ringuette GouletCentre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Annie LauzierCentre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Antoine GuyonCentre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.ORCID 0000-0003-3426-9107
Bertrand NeveuCentre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Frédéric PouliotCentre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.ORCID 0000-0002-6651-1079
Université Laval · CA

Funding

Canadian Foundation for Innovation 32441Fonds de recherche du Québec FRQS-35020Fonds de Recherche du Québec - Santé FRQS-34894PCC Movember New investigator pilot grant 2012-933PCC Movember Rising Star Grants RS2014-04
6 · The paper itself

Abstract

Prostate cancer (PCa) displays diverse intra-tumoral traits, impacting its progression and treatment outcomes. This study aimed to refine PCa cell culture conditions for dynamic monitoring of androgen receptor (AR) activity at the single-cell level. We introduced an extracellular matrix-Matrigel (ECM-M) culture model, enhancing cellular tracking during bioluminescence single-cell imaging while improving cell viability. ECM-M notably tripled the traceability of poorly adherent PCa cells, facilitating robust single-cell tracking, without impeding substrate permeability or AR response. This model effectively monitored AR modulation by antiandrogens across various PCa cell lines. Single-cell imaging unveiled heterogeneous antiandrogen responses within populations, correlating non-responsive cell proportions with drug IC50 values. Integrating ECM-M culture with the PSEBC-TSTA biosensor enabled precise characterization of ARi responsiveness within diverse cell populations. Our ECM-M model stands as a promising tool to assess heterogeneous single-cell treatment responses in cancer, offering insights to link drug responses to intracellular signaling dynamics. This approach enhances our comprehension of the nuanced and dynamic nature of PCa treatment responses.

Indexed as

Extracellular MatrixProstatic NeoplasmsAndrogen AntagonistsBiosensing TechniquesCell Line, TumorHumansLuminescent MeasurementsMaleMicroscopyReceptors, AndrogenSingle-Cell AnalysisAndrogen AntagonistsReceptors, Androgenantiandrogenbioluminescence imagingdrug responseextracellular matrixheterogeneityMatrigelprostate cancerPSAsingle celltranscriptional-based biosensor

Identifiers

PMID38667168
PMCPMC11048191
OpenAlexW4393993561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.